Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsTOPICALGeneric

ACTINEX

MASOPROCOL

Standard Dose
10%
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview ACTINEX is listed in Drugs@FDA under application 019940 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient MASOPROCOL Form and strength CREAM;TOPICAL - 10% Sponsor UNIV AZ CANCER CTR Submission history Latest submission status date: 1995-06-14 00:00:00.

Structured Monograph

Clinical summary

Approval overview ACTINEX is listed in Drugs@FDA under application 019940 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient MASOPROCOL Form and strength CREAM;TOPICAL - 10% Sponsor UNIV AZ CANCER CTR Submission history Latest submission status date: 1995-06-14 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.